Trial Profile
Adjuvant toremifene versus anastrozole in postmenopausal women with estrogen receptor-positive breast cancer: effects on the serum lipid profile and bone metabolism
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 18 Aug 2011
Price :
$35
*
At a glance
- Drugs Anastrozole (Primary) ; Toremifene (Primary)
- Indications Early breast cancer
- Focus Biomarker; Pharmacodynamics
- 01 Aug 2011 Results published in Breast Cancer Research and Treatment.
- 05 Nov 2010 New trial record.